Near-Complete SARS-CoV-2 Seroprevalence among Rural and Urban Kenyans despite Significant Vaccine Hesitancy and Refusal
Authors:
- Carolyne NasimiyuCNCarolyne Nasimiyu
- Isaac NgereINIsaac Ngere
- Jeanette DawaJDJeanette Dawa
- Patrick AmothPAPatrick Amoth
- Ouma OlugaOOOuma Oluga
- Carol NgunuCNCarol Ngunu
- Harriet MirieriHMHarriet Mirieri
- John GachohiJGJohn Gachohi
- Moshe DayanMDMoshe Dayan
- Nzisa LikuNLNzisa Liku
- Ruth NjorogeRNRuth Njoroge
- Raymond OdinohRORaymond Odinoh
Open Access
Abstract
Considering the early inequity in global COVID-19 vaccine distribution, we compared the level of population immunity to SARS-CoV-2 with vaccine uptake and refusal between rural and urban Kenya two years after the pandemic onset. A population-based seroprevalence study was conducted in the city of Nairobi (n = 781) and a rural western county (n = 810) between January and February 2022. The overall SARS-CoV-2 seroprevalence was 90.2% (95% CI, 88.6–91.2%), including 96.7% (95% CI, 95.2–97.9%) among urban and 83.6% (95% CI, 80.6–86.0%) among rural populations. A comparison of immunity profiles showed that >50% of the rural population were strongly immunoreactive compared to 75%), inadequate information (26%), and concern about vaccine effectiveness (9%). Less than 2% of vaccine refusers cited religious or cultural beliefs. These findings indicate that despite vaccine inequity, hesitancy, and refusal, herd immunity had been achieved in Kenya and likely other African countries by early 2022, with natural infections likely contributing to most of this immunity. However, vaccine campaigns should be sustained due to the need for repeat boosters associated with waning of SARS-CoV-2 immunity and emergence of immune-evading virus variants.Keywords
Funding Information
- National Institutes of Health (U01AI151799, D43TW011519)
- Fogarty International Center (U01AI151799, D43TW011519)
This publication has 25 references indexed in Scilit:
- Covid-19 Breakthrough Infections in Vaccinated Health Care WorkersNew England Journal of Medicine, 2021
- Assessing the level and determinants of COVID-19 Vaccine Confidence in KenyamedRxiv, 2021
- Public acceptance of COVID-19 vaccines: cross-national evidence on levels and individual-level predictors using observational dataBMJ Open, 2021
- Knowledge, attitudes, practices, and the effects of COVID-19 among the youth in KenyaBMC Public Health, 2021
- Trust in a COVID-19 vaccine in the U.S.: A social-ecological perspectiveSocial Science & Medicine, 2021
- Acceptance of the COVID-19 vaccine based on the health belief model: A population-based survey in Hong KongVaccine, 2021
- Planning for a COVID-19 Vaccination ProgramJAMA, 2020
- How to Calculate Sample Size for Different Study Designs in Medical Research?Indian Journal of Psychological Medicine, 2013
- Testing four competing theories of health-protective behavior.Health Psychology, 1993
- Testing four competing theories of health-protective behavior.Health Psychology, 1993